Miami officials released a statement Thursday night saying that more than 10,000 drug tests performed by the university since 2005 have resulted in no positive results for anabolic steroids by its athletes.
The statement came amid reports that the school and its baseball program has been linked to an ongoing Major League Baseball investigation into whether players — many of whom either train at or played collegiately at Miami — have been getting performance-enhancing drugs from anti-aging clinics in South Florida.
It's a rare step for Miami, which as a private institution typically does not release sensitive information such as details of its drug-testing policy publicly.
Miami officials released the following statement:
"The University of Miami's comprehensive drug testing policy, enacted in 1995, continues to evolve as the methods and reliability of testing have improved and as more drugs have been introduced into the world of competitive sports.
The University's program is monitored by a University committee, which includes medical professionals, and is overseen by a Medical Review Officer--currently, a former UM Miller School of Medicine physician--who ensures the integrity and confidentiality of the drug testing program. An outside third-party firm administers the tests and provides results to the University.
Since 2005, approximately 3,380 student-athletes have been tested more than 10,000 times by the University, in addition to drug tests administered by the NCAA. During that period, no student-athlete has tested positive for anabolic steroids. The University of Miami, like many of our peer institutions, the NCAA and many professional sports leagues, does not currently test for Human Growth Hormones.
The University of Miami's drug testing policy is consistent with those at most NCAA Division I programs and provides more stringent penalties--including game suspensions for first-time positive results--than many of our peers.
As stated last week, we have initiated an internal review involving an employee and will continue to monitor developments."